Scinai Immunotherapeutics (SCNI) Interest Expenses (2014 - 2025)
Scinai Immunotherapeutics (SCNI) posted Interest Expenses of $28.5 million for Q4 2025, up 1976.98% sequentially from $1.4 million in Q4 2024, and up 1976.98% YoY from $1.4 million in Q4 2024.
Scinai Immunotherapeutics (SCNI) Interest Expenses (2014 - 2025) Analysis & Trends
Scinai Immunotherapeutics has reported Interest Expenses for 12 years, with the latest figure at $28.5 million in Q4 2025.
- Quarterly Interest Expenses rose 1976.98% year-over-year to $28.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $1.4 million (changed 0.0% YoY) and the FY2025 annual result came in at $28.5 million, up 20.33% from the prior year.
- Interest Expenses grew to $28.5 million in Q4 2025 per SCNI's latest filing, from $1.4 million in the prior quarter.
- Over five years, Interest Expenses peaked at $28.5 million in Q4 2025 and troughed at -$5.1 million in Q3 2022.
- A 5-year average of $1.8 million and a median of $108000.0 in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2021 and 2025: Interest Expenses sank 25658.33% in 2021, then soared 1976.98% in 2025.
- Over 5 years, Interest Expenses stood at $8.6 million in 2021, then plunged by 60.06% to $3.4 million in 2022, then sank by 96.87% to $108000.0 in 2023, then jumped by 1171.3% to $1.4 million in 2024, then jumped by 1976.98% to $28.5 million in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered $28.5 million, $1.4 million, and $143000.0 for Q4 2025, Q4 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.52 Mn |
| Dec 31, 2025 | 28.52 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Mar 31, 2024 | 143,000.00 |
| Mar 31, 2024 | 143,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Sep 30, 2023 | -771,000.00 |
| Sep 30, 2023 | -771,000.00 |
| Jun 30, 2023 | 771,000.00 |
| Jun 30, 2023 | 771,000.00 |
| Mar 31, 2023 | 725,000.00 |
| Mar 31, 2023 | 725,000.00 |
| Dec 31, 2022 | 3.45 Mn |
| Dec 31, 2022 | 3.45 Mn |
| Sep 30, 2022 | -5.14 Mn |
| Sep 30, 2022 | -5.14 Mn |
| Jun 30, 2022 | -3.64 Mn |
| Jun 30, 2022 | -3.64 Mn |